Philip Chennell
6
Documents
Publications
- 2
- 1
- 1
- 2
- 6
- 6
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
Ex Vivo Model to Assess the Exposure of Patients to Plasticizers from Medical Devices during Pre-CAR-T Cells’ ApheresisToxics, 2022, 10 (2), pp.79. ⟨10.3390/toxics10020079⟩
Article dans une revue
hal-03726351v1
|
|
|
Physicochemical Stability of Monoclonal Antibodies: A Review.Journal of Pharmaceutical Sciences, 2020, ⟨10.1016/j.xphs.2019.08.009⟩
Article dans une revue
hal-02385936v1
|
|
Stability of infliximab solutions in different temperature and dilution conditionsJournal of Pharmaceutical and Biomedical Analysis, 2018, 150, pp.386 - 395. ⟨10.1016/j.jpba.2017.12.012⟩
Article dans une revue
hal-01705093v1
|
A Sorption Study between Ophthalmic Drugs and Multi Dose Eyedroppers in Simulated Use ConditionsPharmaceutical Technology in Hospital Pharmacy, 2017, 2 (4), pp.181-191. ⟨10.1515/pthp-2017-0026⟩
Article dans une revue
hal-01701788v1
|
Ophthalmic drugs and multi dose eyedroppers: a study of container-content interactions in simulated use conditions20èmes journées du GERPAC, Oct 2017, Hyères, France
Communication dans un congrès
hal-02387539v1
|
Plasticizers exposure in nicu: is it an issue for the patients?European society of clinical pharmacy - Spring Workshop 2022 (ESCP 2022), Apr 2022, Zürich, Switzerland. Springer, International Journal of Clinical Pharmacy, 44, pp.823, 2022, ⟨10.1007/s11096-022-01432-5⟩
Poster de conférence
hal-04027067v1
|